| 2024年年报 | 2023年年报 | |
|---|---|---|
| 营业收入(元) | ||
| 吡啶类(元) | 66,236,033.20 | 59,141,639.12 |
| 硫化物(元) | 48,664,513.29 | 81,474,074.99 |
| 其他(元) | 2,583,881.36 | 17,220,655.10 |
| 营业成本(元) | ||
| 吡啶类(元) | 74,080,962.77 | 65,669,854.07 |
| 硫化物(元) | 58,820,042.46 | 74,240,851.16 |
| 其他(元) | 2,768,223.83 | 13,139,875.84 |
| 毛利(元) | ||
| 吡啶类(元) | -7,844,929.57 | -6,528,214.95 |
| 硫化物(元) | -10,155,529.17 | 7,233,223.83 |
| 其他(元) | -184,342.47 | 4,080,779.26 |
| 毛利率(%) | ||
| 吡啶类(%) | -11.84 | -11.04 |
| 硫化物(%) | -20.87 | 8.88 |
| 其他(%) | -7.13 | 23.70 |
| 收入构成(%) | ||
| 吡啶类(%) | 56.38 | 37.47 |
| 硫化物(%) | 41.42 | 51.62 |
| 其他(%) | 2.20 | 10.91 |
| 毛利构成(%) | ||
| 吡啶类(%) | - | -136.41 |
| 硫化物(%) | - | 151.14 |
| 其他(%) | - | 85.27 |
